Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Rhythm Biosciences Ltd. ( (AU:RHY) ) has shared an update.
Rhythm Biosciences Ltd announced that its 2025 Annual General Meeting will be held on November 5, 2025, in Melbourne, with the closing date for director nominations set for September 17, 2025. This meeting is significant for the company’s governance and strategic direction, potentially impacting its operations and positioning in the cancer diagnostics industry.
More about Rhythm Biosciences Ltd.
Rhythm Biosciences Ltd is an Australian medical diagnostics company focused on delivering simple and affordable blood tests for the early detection of cancers. The company aims to improve patient outcomes by detecting cancer at the earliest possible stage, thereby reducing the global cancer burden and saving lives. Founded in 2017 and headquartered in Melbourne, Australia, Rhythm Biosciences collaborates with global partners to commercialize and distribute its solutions.
Average Trading Volume: 795,664
Technical Sentiment Signal: Sell
Current Market Cap: A$26.66M
For an in-depth examination of RHY stock, go to TipRanks’ Overview page.